MIT researchers have developed a new ingestible pill that expands once it reaches the stomach and could be used to monitor a patient’s health, reports the BBC News. “The dream is to have a smart pill, that once swallowed stays in the stomach and monitors the patient's health for a long time, such as a month,” explains Prof. Xuanhe Zhao.
Guardian reporter Ian Sample writes that MIT startup Synlogic are developing a “living” medicine” made from genetically modified bugs. “By engineering these bacteria, we are able to control how they operate in the human gastrointestinal tract,” says Caroline Kurtz of Synlogic. “It allows us to think about many other diseases where you may need to produce something beneficial, or remove something that is toxic for the patient.”
In an article for The Wall Street Journal, Benjamin Powers highlights Affectiva and Koko, two MIT startups developing AI systems that respond to human emotions.
Prof. Linda Griffith speaks with Hari Sreenivasan of PBS NewsHour about her work developing a new “body on a chip” that could allow researchers to test new drugs on organ tissue. Griffith explains that the device models how different organs and cells communicate in the human body, which is “really important for things like arthritis, Alzheimer's, where you've got multiple organs involved.”
MIT researchers have developed a new system to detect contaminated food by scanning a product’s RFID tags, reports Devin Coldewey for TechCrunch. The system can “tell the difference between pure and melamine-contaminated baby formula, and between various adulterations of pure ethyl alcohol,” Coldewey explains.
TechCrunch reporter Ingrid Lunden highlights RapidSOS, an MIT startup that “helps increase the funnel of information that is transmitted to emergency services alongside a call for help.”
Prof. Linda Griffith speaks with Wall Street Journal reporter Mark Ellwood about her work developing a new device that allows researchers to test how a drug affects the human body. Ellwood notes that the technology that Griffith and her team have created “could prove vital for rapidly releasing new vaccines.”
In an article for Forbes, Charles Towers-Clark spotlights how MIT researchers developed a surgical technique that allows amputees to receive feedback from prosthetic limbs. The technique, Towers-Clark writes, “uses a muscle graft from another part of the body to complete the muscle pair, avoiding rejection which currently occurs in around 20% of cases, and allowing the patient to communicate naturally with the new limb.”
MIT Media Lab graduate student Artem Dementyev has created a palm-sized robot with suction-cup feet, known as SkinBot, which can crawl along the body, writes Douglas Heaven of New Scientist. The robot was designed to “carry out a medical inspection of a patient when there is no doctor nearby or when it would be too dangerous for a doctor to approach,” explains Heaven.
MIT researchers have developed a machine learning system that could reduce the number of chemotherapy and radiotherapy treatments that glioblastoma patients receive, reports the Xinhua News Agency. The system “finds an optimal treatment plan, with the lowest possible potency and frequency of doses that should still reduce tumor sizes,” Xinhua explains.
Researchers from MIT’s Little Devices Lab have developed Lego-like devices that can perform diagnostic tests, writes UPI reporter Allen Cone. The devices could significantly reduce the cost of diagnostic tests and as they don't require refrigeration or special handling, “they could be particularly useful in the developing world.”
Empatica, a startup co-founded by Prof. Rosalind Picard, is hoping to use the same data gathered by its wearable device Embrace, which “analyzes physiological signals to detect seizures,” to help people manage stress, reports Rina Raphael of Fast Company. “We’re developing the applications that can help people understand stress,” says Picard, “the technology is there.”
Fast Company reporter Adele Peters writes that MIT researchers have designed a kit that allows scientists to develop diagnostic tests quickly and cheaply. The kit, “uses modular blocks that can be connected in different patterns to replicate the function that would typically be built into a manufactured test for pregnancy, glucose, or an infection or other disease.”
In an article for Salon, Associate Prof. Noelle Eckley Selin and postdoc Sae Yun Kwon discuss their latest research, which examined emissions in China. They write that although mercury pollution is often associated with fish consumption, “China’s future emissions trajectory can have a measurable influence on the country’s rice methylmercury” levels, as well.
In an opinion piece for The Boston Globe, Alex Amouyel, executive director of MIT Solve, explains how the initiative is ‘crowdsolving’ thorny global problems through open innovation. “We need to source ideas from innovators all around the world to find the next breakthroughs,” argues Amouyel. “We know talent and ingenuity exist everywhere.”